🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to determine the efficacy and safety of durvalumab i...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-12-21
Trial ID
NCT03742102
Treatments Being Tested
The study is intended to assess the safety and efficacy of perioperative tr...
Status
Recruiting
Location
Research Site
Start Date
2022-04-14
Trial ID
NCT05061550
Choice Of the Most Active Strategies for Short term recurring Triple Negati...
Status
Recruiting
Location
Gustave Roussy
Start Date
2024-07-05
Trial ID
NCT06508216
Treatments Being Tested
Phase 2 Platform Study in Patients with Advanced Non-Small Lung Cancer who ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-06-25
Trial ID
NCT03944772
This is a Phase III, randomized, open-label, 3-arm, multicenter, internatio...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-11-28
Trial ID
NCT05629585
Treatments Being Tested
This is a Phase III, randomized, open-label, multicenter, global study to c...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-12-29
Trial ID
NCT05687266
Treatments Being Tested
This study will assess safety, tolerability, and treatment activity of dato...
Status
Active Not Recruiting
Location
Research Site
Start Date
2021-02-02
Trial ID
NCT04612751
Treatments Being Tested
This is a Phase III, 2-arm, randomised, open-label, multicentre, global stu...
Status
Active Not Recruiting
Location
Research Site
Start Date
2023-11-14
Trial ID
NCT06112379
The purpose of this study is to further advance the ability to practice per...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2010-03-01
Trial ID
NCT01042379
Treatments Being Tested
The DIAMOND study is being carried out to evaluate if Datopotamab deruxteca...
Status
Recruiting
Location
Barts Cancer Institute, Centre of Experimental Cancer Medicine
Start Date
2025-10-27
Trial ID
NCT06954480
Treatments Being Tested